京东健康全网独家首发微芯生物创新药爱谱沙 全渠道助力创新疗法高效可及

砍柴网
22 Jul

日前,由深圳微芯生物科技股份有限公司自主研发的全球首创口服选择性组蛋白去乙酰化酶(HDAC)抑制剂爱谱沙®(西达本胺)在京东健康全网独家首发。京东健康将充分发挥全渠道优势和医疗健康服务能力,加速创新药物普惠可及,让广大患者获益。爱谱沙®于2014年获批用于外周T细胞淋巴瘤,填补了中国该领域治疗药物的空白。2019年,其适应症拓展至实体瘤领域,获批用于治疗乳腺癌。2024年,爱谱沙®以联合疗法突破...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10